Maria Chiara Paganotto1/2 ,MD Lucia Amadori2, MD Paolo Busacchi2,MD
1Scuola di Specializzazione in Ginecologia ed Ostetricia
Dipartimento di Scienze Mediche e Chirurgiche
Università di Bologna, Alma Mater Studiorum
Direttore: Professor Nicola Rizzo
2 Unità operativa di Ginecologia e Fisiopatologia della Riproduzione Umana, Azienda Ospedaliero-Universitaria Policlinico S.Orsola-Malpighi, Università
di Bologna
Topic: Prolapse Surgery
Abstract
Aim: To compare the safety and efficacy of two methods used for the prevention of vaginal vault prolapse performed after vaginal hysterectomy
in patients with advanced uterovaginal prolapse.
Materials and Methods: A randomized controlled trial begun in July 2013:overall,28 patients were recruited until now. Women undergoing
vaginal hysterectomy for advanced uterovaginal prolapse were randomized using a computer program into one of two groups. Group A were subjected to a hysterectomy
with a vaginal fascial prolapse correction which included modified McCall culdoplasty, while Group B underwent the same surgery with a sacrospinous ligament
fixation. During the follow-up visits (mean follow-up 7,13 months), an objective and a subjective evaluation were performed.
Results: No significant difference between the two groups were observed in operative time, blood loss and postoperative pelvic pain.
At follow-up visits, patients included in the group A had a higher anterior prolapse recurrence(p:0,15,NS), while there were no differences in posterior
(p:0,75,NS) and vault prolapse recurrence (point C:-6cm in all patients; p:0,66,NS). No differences were observed in terms of chronic pelvic pain(p:0,66,NS).
Dyspareunia was higher in patients included in the GROUP B(p:0,34,NS).
Conclusions: Our preliminary results demonstrate no significant differences between the two procedures for the prevention of vaginal
vault prolapse recurrence. In terms of sexual function, Mc Call culdoplasty might be preferred in younger patients.
Tables:
Table 1: Patients’ general characteristics
|
TREATMENT GROUP |
|
|
|
VARIABLES |
GROUP A () |
GROUP B |
p-value |
|
age |
61,50±6,3 |
64,33±6,1 |
NS |
|
BMI (kg/m2) |
26,83±3,6 |
23,34±2,9 |
NS |
|
years of menopause (age) |
47,82±4,8 |
51,27±7,7 |
NS |
|
neonatal weight (g) |
3493,75 ± 702,8 |
3422,22 ± 342,9 |
NS |
|
presence of varicose veins or hernias |
36,4% |
18,2% |
NS |
|
presence of constipation, smoke or diabetes |
36,4% |
27,3% |
NS |
|
family history of prolapse |
33,3% |
60% |
NS |
|
* Significant value: p ≤ 0,05
Table 2: Comparison of perioperative data
PERIOPERATIVE DATA |
TREATMENT GROUP |
|
|
|
VARIABLES |
GROUP A |
GROUP B |
p-value |
|
Postoperative pelvic pain (0-10) |
3,90±2,9 |
4,38±2,8 |
NS |
|
Blood loss (need for blood transfusions) |
0% |
0% |
NS |
|
Immediate post operative complications (urinary or wound infections) |
10% |
0% |
NS |
|
Intraoperative ureteral injuries |
0% |
0% |
NS |
* Significant value: p ≤ 0,05
Table 3: Vaginal vault prolapse recurrence at a mean follow-up of 7.13 months
|
TREATMENT GROUP |
|
|
VAGINAL VAULT PROLAPSE |
GRUPPO A (10pz) |
GRUPPO B (5pz) |
p-value |
RECURRENCE |
1/10 (10%) |
0/5 (0%) |
NS |
* Significant value: p ≤ 0,05